Crosstalk between Aurora-A and p53: Frequent Deletion or Downregulation of Aurora-A in Tumors from p53 Null Mice
Open Access
- 1 February 2007
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 11 (2) , 161-173
- https://doi.org/10.1016/j.ccr.2006.11.025
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesPublished by Elsevier ,2006
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- p53 mutation heterogeneity in cancerBiochemical and Biophysical Research Communications, 2005
- Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase DomainPLoS Medicine, 2005
- P53 and PrognosisNew Insights and Further ComplexityCell, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Global organization of metabolic fluxes in the bacterium Escherichia coliNature, 2004
- Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stressOncogene, 1999
- A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancersThe EMBO Journal, 1998